MDXH MDxHealth SA

NAS · US · Healthcare · Diagnostics & Research · mdxhealth.com

0.5998USD-0.02%Mkt Cap: 57.23M $P/E: —1d ago

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissu…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$39.97BUSDP/E 35.6

MTD

Mettler-Toledo International Inc.

$30.73BUSDP/E 34.6

Labcorp Holdings Inc.

$25.30BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.06BUSDP/E 24.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.87BUSDP/E 35.5

ERF

Eurofins Scientific SE

$14.23BUSDP/E 26.6

CRL

Charles River Laboratories International, Inc.

$14.34BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap57.23M USD

Enterprise Value117.45M USD

Revenue (TTM)114.02M USD

Gross Profit69.63M USD

Net Income (TTM)-33.52M USD

Revenue/Share2.27 USD

Last Price0.5998 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees364

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.58

PEG—

EV/EBITDA-7.87

EV/Revenue1.03

P/S0.50

P/B-1.01

EPS (TTM)-0.70

EPS (Forward)-0.38

52W Range

0.40004% of range5.330

52W High5.330 USD

52W Low0.4000 USD

Profitability

Gross Margin64.55%

Oper. Margin-18.74%

EBITDA Margin-13.09%

Profit Margin-31.07%

ROE277.15%

ROA-22.66%

Growth

Revenue Growth2.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.19M USD

CapEx (TTM)1.16M USD

FCF Margin-15.26%

FCF Yield-30.41%

Net Debt86.64M USD

Net Debt/EBITDA-5.80

Balance Sheet

Debt/Equity-7.16

Current Ratio1.15

Quick Ratio0.91

Book Value/Sh-0.59 USD

Cash/Share0.37 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)1.800 USD

Upside (mean)+200.1%

Target Range1.000 USD – 3.000 USD

1.000+200.1% to mean3.000

# Analysts5

Ownership

Shares Out.95.42M

Float42.51M

Insiders22.14%

Institutions45.15%

Short Interest

Short Ratio1.7d

Short % Float1.83%

Short % Out.1.59%

Shares Short1.52M

Short (prev mo.)1.45M

Technical

SMA 500.6120 (-2.0%)

SMA 2001.811 (-66.9%)

Beta-518287.38

S&P 52W Chg15.78%

Avg Vol (30d)258.26K

Avg Vol (10d)205.75K

Technical Indicators

RSI (14)48.2

MACD-0.0145

MACD Signal-0.0111

MACD Hist.-0.0034

BB Upper0.7316 USD

BB Middle0.6173 USD

BB Lower0.5029 USD

BB Width37.06%

ATR (14)0.0489 USD

Vol Ratio (20d)1.55x